Details of the Drug

General Information of Drug (ID: DMK8PTH)

Drug Name
PRM-151
Indication
Disease Entry ICD 11 Status REF
Idiopathic pulmonary fibrosis CB03.4 Phase 2 [1]
Macular degeneration 9B78.3 Phase 2 [2]
Myelofibrosis 2A20.2 Phase 2 [1]
Polycythemia vera 2A20.4 Phase 2 [3]
Thrombocythemia 3B63 Phase 2 [3]
Cross-matching ID
TTD ID
D09EDA
Repurposed Drugs (RPD) Click to Jump to the Detailed RPD Information of This Drug

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Neuronal pentraxin-2 (NPTX2) TTNJ5A6 NPTX2_HUMAN Modulator [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 PRM-151 (recombinant human serum amyloid P/pentraxin 2) for the treatment of fibrosis. Drug News Perspect. 2010 Jun;23(5):305-15.
3 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)